{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:26Z","timestamp":1790845586767,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bulcan.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T12:34:17Z","timestamp":1683635657000},"page":"720-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u00c9pargne n\u00e9phronique dans la prise en charge des tumeurs r\u00e9nales malignes solides localis\u00e9es"],"prefix":"10.1016","volume":"111","author":[{"given":"Sylvain","family":"Bodard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Bibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Boudhabhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Delavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Olivier","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"M\u00e9jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"H\u00e9l\u00e9non","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Guinebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Correas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2023.04.005_bib0435","series-title":"Renal mass","author":"Ballard","year":"2022"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0440","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0445","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36\u00a0cancers in 185\u00a0countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0450","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0455","unstructured":"Increasing incidence of all stages of kidney cancer in the last 2\u00a0decades in the United States: an analysis of surveillance, epidemiology and end results program data\u00a0\u2013\u00a0PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/11743275\/ (accessed October 30, 2022)."},{"key":"10.1016\/j.bulcan.2023.04.005_bib0460","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.juro.2006.07.144","article-title":"The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program","volume":"176","author":"Nguyen","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0465","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cncr.23518","article-title":"Renal cell cancer stage migration: analysis of the National Cancer Data Base","volume":"113","author":"Kane","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0470","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.urolonc.2019.11.003","article-title":"Management of small renal masses in patients with chronic kidney disease: perspectives from a nephrologist","volume":"38","author":"Chang","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0475","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0480","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","article-title":"Hypertension and obesity and the risk of kidney cancer in 2\u00a0large cohorts of US men and women","volume":"63","author":"Sanfilippo","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0485","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1016\/j.transproceed.2008.08.135","article-title":"Tumours in end-stage kidney","volume":"40","author":"Hora","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0490","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/nep.13555","article-title":"Higher risk of malignant neoplasms in young adults with end-stage renal disease receiving haemodialysis: a nationwide population-based study","volume":"24","author":"Pan","year":"2019","journal-title":"Nephrology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0495","article-title":"[Cancer imaging and prevention of renal failure]","author":"Bodard","year":"2022","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0500","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0505","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0090-4295(97)00506-2","article-title":"Increased incidence of serendipitously discovered renal cell carcinoma","volume":"51","author":"Jayson","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0510","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0044-101254","article-title":"The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version)","volume":"39","author":"Sidhu","year":"2018","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0515","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1166-7087(20)30749-1","article-title":"[French ccAFU guidelines\u00a0\u2013\u00a0update 2020\u20132022: management of kidney cancer]","volume":"30","author":"Bensalah","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0520","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.purol.2022.07.146","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0update 2022\u20132024: management of kidney cancer","volume":"32","author":"Bigot","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0525","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Escudier","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0530","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2016.69.9645","article-title":"Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Finelli","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0535","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0540","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2014.09.027","article-title":"Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function","volume":"67","author":"Capitanio","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0545","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cncr.23218","article-title":"Renal and cardiovascular morbidity after partial or radical nephrectomy","volume":"112","author":"Miller","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0550","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0555","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JU.0000000000000326","article-title":"Chronic kidney disease and kidney cancer surgery: new perspectives","volume":"203","author":"Huang","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0560","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/M17-0585","article-title":"Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer","volume":"169","author":"Talenfeld","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0565","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.eururo.2010.02.019","article-title":"Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma","volume":"57","author":"Bernhard","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0570","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","article-title":"The R.E.N.A.L.\u00a0nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth","volume":"182","author":"Kutikov","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0575","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.urology.2015.10.034","article-title":"Mayo adhesive probability score is associated with localized renal cell carcinoma progression-free survival","volume":"89","author":"Thiel","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0580","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2011.05.030","article-title":"Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy","volume":"60","author":"Simhan","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0585","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.euf.2018.10.016","article-title":"What is better for predicting morbidity of robotic partial nephrectomy\u00a0\u2014\u00a0a score or your clinical judgement?","volume":"6","author":"Khene","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0590","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2009.03.048","article-title":"Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery","volume":"57","author":"Bensalah","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0595","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.juro.2017.09.072","article-title":"Local tumor bed recurrence following partial nephrectomy in patients with small renal masses","volume":"199","author":"Wood","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0600","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.euf.2021.02.007","article-title":"Percutaneous ablation versus surgical resection for local recurrence following partial nephrectomy for renal cell cancer: a propensity score analysis (REPART study\u00a0\u2014\u00a0UroCCR 71)","volume":"8","author":"Brassier","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0605","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1089\/end.2020.1041","article-title":"Radiofrequency ablation of small renal masses","volume":"35","author":"Dai","year":"2021","journal-title":"J Endourol"},{"issue":"Suppl 1","key":"10.1016\/j.bulcan.2023.04.005_bib0610","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S1166-7087(16)30702-3","article-title":"[CCAFU french national guidelines 2016\u20132018\u00a0on renal cancer]","volume":"27","author":"Bensalah","year":"2016","journal-title":"Prog Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0615","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/089277902320913242","article-title":"Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine model","volume":"16","author":"Gettman","year":"2002","journal-title":"J Endourol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0620","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/end.1994.8.153","article-title":"Laparoscopic interstitial contact laser ablation of renal lesions: an experimental model","volume":"8","author":"Lotfi","year":"1994","journal-title":"J Endourol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0625","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2019.04.026","article-title":"Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1\u00a0renal masses","volume":"76","author":"Andrews","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0630","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00330-018-5660-3","article-title":"Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis","volume":"29","author":"Uhlig","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0635","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","article-title":"Comparison of partial nephrectomy and percutaneous ablation for cT1\u00a0renal masses","volume":"67","author":"Thompson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0640","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.euo.2020.02.001","article-title":"Limitations of available studies prevent reliable comparison between tumour ablation and partial nephrectomy for patients with localised renal masses: a systematic review from the European Association of Urology Renal Cell Cancer Guideline Panel","volume":"3","author":"Abu-Ghanem","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0645","unstructured":"Systematic review of oncological outcomes following surgical management of localised renal cancer\u00a0\u2013\u00a0PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/22405593\/ (accessed January 2, 2023)."},{"key":"10.1016\/j.bulcan.2023.04.005_bib0650","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u00a0\u2013\u00a0a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0655","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2019.04.026","article-title":"Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1\u00a0renal masses","volume":"76","author":"Andrews","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0665","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.euo.2018.08.029","article-title":"The role of ablation and minimally invasive techniques in the management of small renal masses","volume":"1","author":"Salagierski","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0670","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00270-016-1417-z","article-title":"Percutaneous radiofrequency ablation versus robotic-assisted partial nephrectomy for the treatment of small renal cell carcinoma","volume":"39","author":"Pantelidou","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0675","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2215\/CJN.11941116","article-title":"Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis","volume":"12","author":"Patel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0680","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00270-014-0846-9","article-title":"Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours","volume":"37","author":"Katsanos","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0685","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s00261-018-1612-2","article-title":"Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology","volume":"43","author":"Yano","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0690","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00270-016-1531-y","article-title":"CIRSE guidelines on percutaneous ablation of small renal cell carcinoma","volume":"40","author":"Krokidis","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0695","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.3390\/cancers14204969","article-title":"Percutaneous thermal ablation for renal tumors in patients with Birt-Hogg-Dub\u00e9 syndrome","volume":"14","author":"Bodard","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0700","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.diii.2017.03.004","article-title":"The future of percutaneous renal ablation","volume":"98","author":"Cornelis","year":"2017","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0705","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.diii.2019.06.009","article-title":"Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dub\u00e9 syndrome","volume":"100","author":"Matsui","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0710","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/radiol.2481071448","article-title":"Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis","volume":"248","author":"Pandharipande","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0715","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1464-410X.2012.11432.x","article-title":"Percutaneous cryoablation of renal masses: Washington university experience of treating 129\u00a0tumours","volume":"111","author":"Kim","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0720","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","article-title":"Active surveillance of small renal masses: progression patterns of early stage kidney cancer","volume":"60","author":"Jewett","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0725","first-page":"100","article-title":"The natural history of incidentally detected small renal masses","author":"A V","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0730","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1464-410X.2012.11130.x","article-title":"Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy","volume":"110","author":"Patel","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0735","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bju.14490","article-title":"Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study","volume":"123","author":"Alam","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0740","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/bju.14486","article-title":"Conditional survival of patients with small renal masses undergoing active surveillance","volume":"123","author":"Petros","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0745","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.clgc.2021.09.008","article-title":"Disease progression in older patients with renal tumor assigned to an active surveillance protocol","volume":"20","author":"Jakubowicz","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0750","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/JU.0000000000001575","article-title":"Outcomes of active surveillance for young patients with small renal masses: prospective data from the DISSRM registry","volume":"205","author":"Metcalf","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0755","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.euf.2019.10.004","volume":"7","author":"Correa","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0760","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/s12885-018-4916-2","article-title":"TROG 15.03\u00a0phase II clinical trial of focal ablative stereotactic radiosurgery for cancers of the kidney\u00a0\u2013\u00a0FASTRACK II","volume":"18","author":"Siva","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0765","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.31156","article-title":"Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","volume":"124","author":"Siva","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0770","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2020.06.014","article-title":"Stereotactic ablative radiotherapy for\u2265T1b primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)","volume":"108","author":"Siva","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0775","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ijrobp.2021.01.054","article-title":"Neoadjuvant SABR for renal cell carcinoma inferior vena cava tumor thrombus-safety lead-in results of a phase 2\u00a0trial","volume":"110","author":"Margulis","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0780","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-16-2946","article-title":"A pilot study of stereotactic body radiation therapy combined with cytoreductive nephrectomy for metastatic renal cell carcinoma","volume":"23","author":"Singh","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0785","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0790","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.eururo.2015.04.004","article-title":"Renal tumor biopsy for small renal masses: a single-center 13-year experience","volume":"68","author":"Richard","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0795","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bju.13630","article-title":"Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry","volume":"119","author":"Richard","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0800","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2019.08.043","article-title":"Renal mass biopsy is associated with reduction in surgery for early-stage kidney cancer","volume":"135","author":"Patel","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0805","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.euros.2021.06.004","article-title":"Utilization of renal mass biopsy for T1\u00a0renal lesions across Michigan: results from MUSIC-KIDNEY. A statewide quality improvement collaborative","volume":"30","author":"Patel","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0810","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11934-021-01064-8","article-title":"Renal tumor biopsy: rationale to avoid surgery in small renal masses","volume":"22","author":"Amaral","year":"2021","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.05.024","article-title":"Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses?","volume":"39","author":"Okhunov","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0820","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/21681805.2019.1703805","article-title":"Does renal mass biopsy influence multidisciplinary treatment recommendations?","volume":"54","author":"Lobo","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0825","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3390\/jcm11143944","article-title":"Quality of life and psychological distress among patients with small renal masses","volume":"11","author":"Vartolomei","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0830","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10865-014-9578-1","article-title":"Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinoma","volume":"38","author":"Prinsloo","year":"2015","journal-title":"J Behav Med"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0835","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1756287218754766","article-title":"Analysis of psychosocial stress factors in patients with renal cancer","volume":"10","author":"Draeger","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0840","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bju.14564","article-title":"Distress in patients with renal cell carcinoma: a curious gap in knowledge","volume":"123","author":"Bergerot","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0845","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.juro.2016.04.073","article-title":"A prospective, comparative study of quality of life among patients with small renal masses choosing active surveillance and primary intervention","volume":"196","author":"Patel","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0850","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry","volume":"68","author":"Pierorazio","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0855","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.urolonc.2018.10.001","article-title":"Use of delayed intervention for small renal masses initially managed with active surveillance","volume":"37","author":"Gupta","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bulcan.2023.04.005_bib0430","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.urology.2016.04.067","article-title":"Predictors of delayed intervention for patients on active surveillance for small renal masses: does renal mass biopsy influence our decision?","volume":"98","author":"Ambani","year":"2016","journal-title":"Urology"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T02:03:32Z","timestamp":1719713012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":86,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0007455123001996"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.04.005","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9pargne n\u00e9phronique dans la prise en charge des tumeurs r\u00e9nales malignes solides localis\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}